ArticleBio-protocol2026
Enhancement of RNA Imaging Platforms by the Use of Peptide Nucleic Acid-Based Linkers.
Article in Bio-protocol, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Technologies for RNA Detection.Bio-protocol · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
RNA imaging techniques enable researchers to monitor RNA localization, dynamics, and regulation in live or fixed cells. While the MS2-MCP system-comprising the MS2 RNA hairpin and its binding partner, the MS2 coat protein (MCP)-remains the most widely used approach, it relies on a tag containing multiple fluorescent proteins and has several limitations, including the potential to perturb RNA function due to the tag's large mass. Alternative methods using small-molecule binding aptamers have been developed to address these challenges. This protocol describes the synthesis and characterization of RNA-targeting probes incorporating a peptide nucleic acid (PNA)-based linker within the cobalamin (Cbl)-based probe of the Riboglow platform. Characterization in vitro involves a fluorescence turn-on assay to determine binding affinity (K
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.